PEGFILGRASTIM , PACLITAXEL , DOXORUBICIN , Rinatabart Sesutecan, GEMCITABINE , TOPOTECAN
GCT1184-02
Phase 3 small_molecule active
Quick answer
PEGFILGRASTIM , PACLITAXEL , DOXORUBICIN , Rinatabart Sesutecan, GEMCITABINE , TOPOTECAN for Platinum-resistant Ovarian Cancer is a Phase 3 program (small_molecule) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Platinum-resistant Ovarian Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active